No­var­tis-part­nered biotech nabs new cash, boost­ing ef­forts to de­vel­op 'func­tion­al cure' for chron­ic he­pati­tis B

Every year, 820,000 peo­ple die of chron­ic he­pati­tis B in­fec­tions glob­al­ly, and 1.5 mil­lion get in­fect­ed, de­spite the avail­abil­i­ty of vac­cines and treat­ments, ac­cord­ing to …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER